MHRA – Class 4 Medicines Defect Information: Venlafaxine XL 300 mg prolonged-release tablets (Macarthys Laboratories t/a Martindale Pharma)
Class 4 Medicines Defect Information: Venlafaxine XL 300 mg prolonged-release tablets (Macarthys Laboratories t/a Martindale Pharma) Drug alert number: EL (22)A/47 Date issued: 16 November 2022 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Venlafaxine XL 300 mg prolonged-release tablets, PL 01883/0363 Batch Number Expiry [...]
The post MHRA – Class 4 Medicines Defect Information: Venlafaxine XL 300 mg prolonged-release tablets (Macarthys Laboratories t/a Martindale Pharma) appeared first on PSNC Website.
Recent Comments